Literature DB >> 33795426

Medicaid Expansion and Incidence of Kidney Failure among Nonelderly Adults.

Rebecca Thorsness1, Shailender Swaminathan2,3, Yoojin Lee2, Benjamin D Sommers4,5, Rajnish Mehrotra6, Kevin H Nguyen2, Daeho Kim2, Maricruz Rivera-Hernandez2, Amal N Trivedi2,3.   

Abstract

BACKGROUND: Low-income individuals without health insurance have limited access to health care. Medicaid expansions may reduce kidney failure incidence by improving access to chronic disease care.
METHODS: Using a difference-in-differences analysis, we examined the association between Medicaid expansion status under the Affordable Care Act (ACA) and the kidney failure incidence rate among all nonelderly adults, aged 19-64 years, in the United States, from 2012 through 2018. We compared changes in kidney failure incidence in states that implemented Medicaid expansions with concurrent changes in nonexpansion states during pre-expansion, early postexpansion (years 2 and 3 postexpansion), and later postexpansion (years 4 and 5 postexpansion).
RESULTS: The unadjusted kidney failure incidence rate increased in the early years of the study period in both expansion and nonexpansion states before stabilizing. After adjustment for population sociodemographic characteristics, Medicaid expansion status was associated with 2.20 fewer incident cases of kidney failure per million adults per quarter in the early postexpansion period (95% CI, -3.89 to -0.51) compared with nonexpansion status, a 3.07% relative reduction (95% CI, -5.43% to -0.72%). In the later postexpansion period, Medicaid expansion status was not associated with a statistically significant change in kidney failure incidence (-0.56 cases per million per quarter; 95% CI, -2.71 to 1.58) compared with nonexpansion status and the pre-expansion time period.
CONCLUSIONS: The ACA Medicaid expansion was associated with an initial reduction in kidney failure incidence among the entire, nonelderly, adult population in the United States; but the changes did not persist in the later postexpansion period. Further study is needed to determine the long-term association between Medicaid expansion and changes in kidney failure incidence.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  Medicaid; chronic kidney disease; epidemiology and outcomes; health insurance; kidney failure; uninsured

Mesh:

Year:  2021        PMID: 33795426      PMCID: PMC8259656          DOI: 10.1681/ASN.2020101511

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   14.978


  56 in total

1.  Longitudinal progression trajectory of GFR among patients with CKD.

Authors:  Liang Li; Brad C Astor; Julia Lewis; Bo Hu; Lawrence J Appel; Michael S Lipkowitz; Robert D Toto; Xuelei Wang; Jackson T Wright; Tom H Greene
Journal:  Am J Kidney Dis       Date:  2012-01-26       Impact factor: 8.860

2.  Health and Access to Care during the First 2 Years of the ACA Medicaid Expansions.

Authors:  Sarah Miller; Laura R Wherry
Journal:  N Engl J Med       Date:  2017-03-09       Impact factor: 91.245

3.  Economic Effects of Medicaid Expansion in Michigan.

Authors:  John Z Ayanian; Gabriel M Ehrlich; Donald R Grimes; Helen Levy
Journal:  N Engl J Med       Date:  2017-01-04       Impact factor: 91.245

4.  The Affordable Care Act Medicaid Expansions and Personal Finance.

Authors:  Kyle J Caswell; Timothy A Waidmann
Journal:  Med Care Res Rev       Date:  2017-09-16       Impact factor: 3.929

5.  Chronic kidney disease in the urban poor.

Authors:  Yoshio N Hall; Andy I Choi; Glenn M Chertow; Andrew B Bindman
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-03       Impact factor: 8.237

6.  The Oregon experiment--effects of Medicaid on clinical outcomes.

Authors:  Katherine Baicker; Sarah L Taubman; Heidi L Allen; Mira Bernstein; Jonathan H Gruber; Joseph P Newhouse; Eric C Schneider; Bill J Wright; Alan M Zaslavsky; Amy N Finkelstein
Journal:  N Engl J Med       Date:  2013-05-02       Impact factor: 91.245

7.  Blood pressure and end-stage renal disease in men.

Authors:  M J Klag; P K Whelton; B L Randall; J D Neaton; F L Brancati; C E Ford; N B Shulman; J Stamler
Journal:  N Engl J Med       Date:  1996-01-04       Impact factor: 91.245

8.  Association of Medicaid Expansion With Rates of Utilization of Cardiovascular Therapies Among Medicaid Beneficiaries Between 2011 and 2018.

Authors:  Andrew Sumarsono; Hussain Lalani; Matthew W Segar; Shreya Rao; Muthiah Vaduganathan; Rishi K Wadhera; Sandeep R Das; Ann Marie Navar; Gregg C Fonarow; Ambarish Pandey
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-11-09

9.  Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.

Authors:  George L Bakris; Rajiv Agarwal; Stefan D Anker; Bertram Pitt; Luis M Ruilope; Peter Rossing; Peter Kolkhof; Christina Nowack; Patrick Schloemer; Amer Joseph; Gerasimos Filippatos
Journal:  N Engl J Med       Date:  2020-10-23       Impact factor: 91.245

10.  The three-year impact of the Affordable Care Act on disparities in insurance coverage.

Authors:  Charles Courtemanche; James Marton; Benjamin Ukert; Aaron Yelowitz; Daniela Zapata; Ishtiaque Fazlul
Journal:  Health Serv Res       Date:  2018-10-30       Impact factor: 3.402

View more
  3 in total

1.  County-Level Dialysis Facility Supply and Distance Traveled to Facilities among Incident Kidney Failure Patients.

Authors:  Alexis F Velázquez; Rebecca Thorsness; Amal N Trivedi; Kevin H Nguyen
Journal:  Kidney360       Date:  2022-05-24

2.  Evaluation of Racial, Ethnic, and Socioeconomic Disparities in Initiation of Kidney Failure Treatment During the First 4 Months of the COVID-19 Pandemic.

Authors:  Kevin H Nguyen; Rebecca Thorsness; Susan Hayes; Daeho Kim; Rajnish Mehrotra; Shailender Swaminathan; Navya Baranwal; Yoojin Lee; Maricruz Rivera-Hernandez; Amal N Trivedi
Journal:  JAMA Netw Open       Date:  2021-10-01

3.  Structural Inequities and Barriers to Accessing Kidney Healthcare Services in the United States: A Focus on Uninsured and Undocumented Children and Young Adults.

Authors:  Franca M Iorember; Oluwatoyin F Bamgbola
Journal:  Front Pediatr       Date:  2022-04-05       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.